SIM
RLAY icon

Sandia Investment Management’s Relay Therapeutics RLAY Stock Holding History

Sandia Investment Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,908
Closed -$97.3K – 262
2023
Q1 		$97.3K Hold
5,908
– – 0.02% 175
2022
Q4 		$88.3K Hold
5,908
– – 0.02% 171
2022
Q3 		$132K Buy
+5,908
New +$130K 0.02% 188

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Sandia Investment Management's RLAY Position: Q2 2023 in Review

Sandia Investment Management sold out of Relay Therapeutics (RLAY) in Q2 2023, closing a stake of 5,908 shares — an estimated $97.3K sold.

Sandia Investment Management first reported a position in RLAY in Q3 2022 and held it in 3 quarters. The position peaked at $132K in Q3 2022. 161 funds tracked by Wall St. Rank hold RLAY as of Q2 2023.

  • Sandia Investment Management reported no remaining Relay Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Sandia Investment Management sold 5,908 Relay Therapeutics shares in Q2 2023, an estimated $97.3K.
  • Sandia Investment Management first reported a position in Relay Therapeutics in Q3 2022 and held it in 3 quarters.
  • Sandia Investment Management's Relay Therapeutics position peaked at $132K in Q3 2022.
  • 161 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2023.

Based on Sandia Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.